Cytokinetics specializes in the discovery, development, and commercialization of innovative drugs that target the cytoskeleton, a framework that affects various cellular functions. Their research focuses on addressing pharmaceutical needs in cancer, cardiovascular, and infectious diseases. They have a strategic collaboration with GlaxoSmithKline to develop small molecule therapeutics for the treatment of cancer and other diseases. Cytokinetics is known for its expertise in muscle biology and is developing drug candidates that impact muscle function and contractility. They have been recognized as a top workplace in the Bay Area.